NASDAQ:INSM - Insmed Incorporated
$22.21
 $-0.51
-2.24%
4:00PM EDT
2019-07-15
Insmed Incorporated, incorporated on March 21, 2013, is a biopharmaceutical company. The Company operates through development and commercialization of therapies for patients with rare diseases segment. The Company's lead product candidate is ARIKAYCE, or liposomal amikacin for inhalation (LAI). Its earlier-stage pipeline includes preclinical compounds that the Company is evaluating in multiple rare diseases of unmet medical need, including methicillin-resistant staph aureus (MRSA) and nontuberculous mycobacteria (NTM). Its earlier clinical-stage pipeline includes INS1007 and INS1009.ARIKAYCEThe Company's ARIKAYCE product is in late-stage development for adult patients with treatment refractory NTM lung disease caused by Mycobacterium avium complex (MAC). ARIKAYCE is administered once-daily, using a portable aerosol delivery system, through an optimized, investigational eFlow Nebulizer System. ARIKAYCE is being evaluated in a Phase III randomized, open-label clinical study taking place in North America, Europe, Australia, New Zealand and Asia that is designed to confirm the culture conversion results seen in its Phase II clinical trial. Its completed Phase II study, which is also known as the 112 study, was a randomized, double-blind, placebo-controlled study. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  INSM     avg for
industry  
  avg for
sector  
42 stocks weight:  46. 85   114. 77   204. 78  
42 stocks rank:  2. 36 K 1. 44 K 810. 33  
# analyst opinions:  9. 00   13. 59   13. 86  
mean recommendation:  1. 90   2. 12   2. 04  

quick ratio:  4. 56   5. 48   1. 89  
current ratio:  4. 82   5. 85   2. 40  

target price low:  30. 00   82. 72   115. 11  
target price avg:  42. 33   104. 42   138. 02  
target price high:  56. 00   130. 64   159. 47  
1-yr high:  32. 19   110. 27   142. 72  
last close:  22. 72   85. 12   126. 54  
50-day avg:  25. 91   86. 06   122. 35  
200-day avg:  23. 21   88. 76   121. 75  
1-yr low:  11. 60   69. 26   100. 63  
volume:  673. 24 K 3. 51 M 5. 53 M
50-day avg volume:  1. 05 M 3. 21 M 4. 22 M
200-day avg volume:  1. 01 M 3. 04 M 4. 75 M

1-day return:  -2. 41 % -0. 30 % -1. 01 %
this week return:  -8. 83 % -2. 16 % -1. 35 %
12-wk return:  -23. 86 % 3. 34 % 8. 69 %
52-wk return:  -7. 77 % -1. 76 % 12. 22 %

enterprise value (EV):  1. 75 B 46. 50 B 123. 99 B
market cap:  2. 01 B 40. 77 B 109. 11 B
EBITDA:  -310. 15 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -5. 66   5. 45   12. 05  
enterprise/revenue (EV/R):  55. 27   50. 46   9. 50  
total revenue:  31. 74 M 10. 21 B 40. 60 B
total debt:  366. 38 M 11. 27 B 17. 58 B
debt/equity:  254. 19   57. 36   120. 25  
net income (common):  -329. 91 M 2. 13 B 4. 27 B

shares outstanding:  77. 67 M 551. 08 M 1. 24 B
shares:  70. 26 M 559. 41 M 1. 22 B
shares short:  12. 20 M 11. 15 M 11. 94 M
shares short prior month:  11. 43 M 9. 31 M 11. 96 M
short ratio:  11. 03   5. 72   3. 43  
short % of float:  27. 27 % 6. 40 % 2. 65 %
total cash/share:  5. 41   11. 00   9. 23  
total cash:  420. 23 M 6. 03 B 6. 01 B
free cash flow:  -145. 69 M 3. 02 B 4. 96 B
operating cash flow:  -264. 41 M 3. 92 B 5. 99 B

book value:  1. 86   13. 02   27. 49  
price/book:  12. 23   4. 21   8. 80  
gross profits:  -78. 99 M 7. 67 B 36. 29 B
operating margins:  -989. 68 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  -178. 76 % 36. 11 % 55. 16 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 50 % 1. 08 %

1-yr EPS:  -4. 29   2. 12   4. 26  
forward EPS:  -2. 52   3. 47   7. 14  
P/E:  -5. 30   2. 15   33. 17  
forward P/E:  -9. 02   -4. 03   17. 60  
PE/G:  0. 41   0. 54   0. 34  
growth:  -13. 05 % 263. 03 % 78. 34 %
earnings high:  -0. 56   0. 91   1. 70  
earnings avg:  -0. 87   0. 71   1. 58  
earnings low:  -1. 02   0. 48   1. 46  
revenue high:  28. 00 M 2. 64 B 11. 26 B
revenue avg:  25. 15 M 2. 58 B 11. 09 B
revenue low:  22. 95 M 2. 54 B 10. 90 B
return on assets:  -28. 68 % -2. 31 % 5. 31 %
return on equity:  -113. 96 % -82. 48 % 135. 30 %
revenue/share:  0. 41   12. 77   61. 38  

beta (1yr vs S&P500):  2. 00   1. 26   0. 91  
sharpe (1yr):  0. 22   0. 07   0. 77  

held % insiders:  1. 16 % 6. 08 % 3. 31 %
held % institutions:  107. 69 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : INSM
.    131.928 =       131.928 :: --> INITIAL WEIGHT <--
.    - 4.288 =        127.64 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.091 =       266.954 :: P/E factor
.    x 1.253 =       334.402 :: PE/G factor
.    x 1.491 =       498.638 :: beta factor
.    x 0.715 =       356.672 :: sharpe factor
.    x 2.824 =      1007.272 :: current ratio factor
.    x 1.132 =      1140.068 :: quick ratio factor
.    x 1.044 =      1190.627 :: short ratio factor
.    x 1.905 =      2267.674 :: EV/R factor
.    x 1.123 =      2547.379 :: price-to-book factor
.    x 0.668 =      1701.896 :: debt-to-revenue factor
.    x 1.899 =      3231.608 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =       6831.57 :: sector+industry 1-year gains factor
.    x 1.033 =       7059.73 :: industry 12-weeks return factor
.    x 1.305 =       9214.88 :: industry 2-weeks return factor
.    x 0.973 =      8963.596 :: company one-year gains+dividend factor
.    x 0.949 =      8510.204 :: company 13 weeks' performance factor
.    x 1.001 =      8518.489 :: 5-day avg > 200-day avg
.    x 1.116 =       9510.02 :: 50-day avg > 200-day avg
.    x 0.971 =      9234.227 :: "drift" penalty 1 days ago
.    / 2.003 =      4609.439 :: overall "drift" factor
.    x 0.879 =      4051.992 :: largest single-day jump factor
.        x 1 =      4051.992 :: volatility factor
.        x 1 =      4051.992 :: 42-day volatility factor
.    x 1.757 =      7120.711 :: notable returns + performance factor
.    x 3.402 =     24227.077 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.745 =     18052.247 :: forward EPS factor
.    x 0.907 =     16380.323 :: forward P/E factor
.    x 1.182 =     19368.894 :: industry recommendation factor
.    x 2.383 =     46165.113 :: company recommendation factor
.    x 1.008 =     46518.199 :: factor historical industry gain for week 28
.    x 1.702 =     79188.821 :: target low factor
.     x 1.31 =    103712.028 :: target mean factor
.    x 1.051 =    108983.912 :: target high factor
.   x 11.329 =   1234627.112 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        33.334 :: reduced for readability
.   + 12.679 =        46.013 :: add/subtract for investor sentiment
.    + 0.833 =        46.846 :: earnings report in 16 days
.                               --> FINAL WEIGHT <--
.                     46.846 :: FINAL WEIGHT for NASDAQ:INSM


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org